Past studies elucidated that SGK3 potentially interacts with and phosphorylates GSK-3β at serine-9, to form the pS9-GSK3β complex, which inactivates GSK3 activity and induces hypertrophic cardiomyopathy 76, 77. Here, GSK3B is linked to hypertrophic cardiomyopathy.